Article Information
History
- June 15, 2022.
Article Versions
- Version 1 (January 2, 2020 - 09:42).
- Version 2 (June 5, 2022 - 09:56).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Douglas Myers-Turnbulla,b,
- Jack C Taylorb,
- Cole Helsella,b,
- Matthew N McCarrollb,c,
- Chris S Kia,1,
- Tia A Tumminoa,b,c,
- Shreya Ravikumarb,2,
- Reid Kinsera,b,
- Leo Gendeleva,b,3,
- Rebekah Alexanderb,4,
- Michael J Keiserb,c,g,5 and
- David Kokelb,c,h,6,*
- aQuantitative Biosciences Consortium, University of California, San Francisco, CA 94143, USA
- bInstitute for Neurodegenerative Diseases, University of California, San Francisco, CA 94143, USA
- cDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA 94143, USA
- gDepartment of Bioengineering & Therapeutic Sciences, University of California, San Francisco, CA 94143, USA
- hDepartment of Physiology, University of California, San Francisco, CA 94143, USA
- ↵* Corresponding author; email: dave.kokel{at}gmail.com